Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster
Open Access
- 12 September 2024
- Vol. 42 (26) , 126354
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (458556631)
This publication has 23 references indexed in Scilit:
- Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in GermanyEpidemiology and Infection, 2022
- Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR projectVaccine, 2022
- Effective incentives for increasing COVID-19 vaccine uptakePsychological Medicine, 2021
- Cancelled routine vaccination appointments due to COVID-19 pandemic in GermanyVaccine: X, 2021
- Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine HesitancyJournal of Community Health, 2021
- Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?Vaccine, 2020
- Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case seriesThe Lancet Infectious Diseases, 2020
- The well-known and less well-known benefits of vaccinesAging Clinical and Experimental Research, 2020
- Vaccination in the elderly: The challenge of immune changes with agingSeminars in Immunology, 2018
- Epidemiology and cost of herpes zoster and postherpetic neuralgia in GermanyThe European Journal of Health Economics, 2012